EUVIMEDEUVIMED entdecken
Crossref

The Mutation Profiles of K-RAS/N-RAS Genes in Metastatic Colorectal Cancer Patients

Seda EREN KESKİN, Eda GÜZDOLU, Nilüfer SERTDEMİR, Gülhan DEMİR, Deniz SÜNNETÇİ AKKOYUNLU, Devrim ÇABUK, Naci ÇİNE, Hakan SAVLI

Kocaeli Üniversitesi Sağlık Bilimleri Dergisi · 2022

DOI: 10.30934/kusbed.1052876 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Kocaeli Üniversitesi Sağlık Bilimleri Dergisi, 2022. Verfasst von Seda EREN KESKİN und 7 weiteren Autor:innen. Die Arbeit nennt 39 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

RAS genes are members of the RAS/Mitogen activated protein kinase pathway which is induced by Epidermal Growth Factor Receptor (EGFR). Mutations in genes in this pathway trigger cancer development. In colorectal cancer, mutations in RAS genes cause resistance to EGRF- targeted therapy. In the treatment of metastatic colorectal cancer, EGFR’s monoclonal antibodies are widely used as chemotherapeutic agents. Kirsten-RAS mutations are found in 30-50% and N-RAS mutations are found in 2-3% of colorectal cancer. In this study, we aimed to analyze Kirsten-RAS /N-RAS mutations in patients with metastatic colorectal cancer.

Methods

One hundred of metastatic colorectal cancer patients resistant to EGFR- targeted therapy were scanned for the Kirsten-RAS mutations status (exon 2,3,4) and N-RAS mutation status (Exon 2,3,4) by Real-Time PCR (Polymerase Chain Reaction) method.

Results

As a result of this study, Kirsten-RAS mutation was found 48% and N-RAS mutation was 1.92%. The most common Kirsten-RAS mutations were in codon 12. The distribution of codon 12 mutations were obtained as G12V (25%), G12D (23%), G12C (14.5%).

Conclusion

In our study, the frequencies of Kirsten-RAS and N-RAS mutations were compitable with similar reports. Our results have supported that testing RAS genes mutations have a vital role in identifying patients who benefit from Epidermal Growth Factor Receptor- targeted therapy.

Zitieren

APA

KESKİN, S. E., GÜZDOLU, E., SERTDEMİR, N., DEMİR, G., AKKOYUNLU, D. S., ÇABUK, D., ÇİNE, N., & SAVLI, H. (2022). The Mutation Profiles of K-RAS/N-RAS Genes in Metastatic Colorectal Cancer Patients. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi. https://doi.org/10.30934/kusbed.1052876

Vancouver

KESKİN SE, GÜZDOLU E, SERTDEMİR N, DEMİR G, AKKOYUNLU DS, ÇABUK D, et al. The Mutation Profiles of K-RAS/N-RAS Genes in Metastatic Colorectal Cancer Patients. Kocaeli Üniversitesi Sağlık Bilimleri Dergisi. 2022. doi:10.30934/kusbed.1052876

BibTeX
@article{KESKN2022,
  author = {KESKİN, Seda EREN and GÜZDOLU, Eda and SERTDEMİR, Nilüfer and DEMİR, Gülhan and AKKOYUNLU, Deniz SÜNNETÇİ and ÇABUK, Devrim and ÇİNE, Naci and SAVLI, Hakan},
  title = {The Mutation Profiles of K-RAS/N-RAS Genes in Metastatic Colorectal Cancer Patients},
  journal = {Kocaeli Üniversitesi Sağlık Bilimleri Dergisi},
  year = {2022},
  doi = {10.30934/kusbed.1052876}
}
Kostenlos starten →